Light switch wakes sleeping cancer cells and makes them vulnerable again

Researchers at ETH Zurich have developed a light-sensitive system to wake dormant cancer cells, making them vulnerable to treatment. By targeting glucocorticoid receptors specifically in tumor cells, the method avoids the systemic side effects associated with traditional hormone-based therapies.
Some cancer cells can enter a dormant, sleep-like state that helps them survive treatment. Instead of continuing to grow and divide, these cells become largely inactive, allowing them to avoid the effects of many cancer drugs.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in